Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BHC NASDAQ:CRON NYSEARCA:THCX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBHCBausch Health Cos$4.53+2.1%$5.00$4.33▼$8.69$1.69B0.422.10 million shs1.05 million shsCRONCronos Group$2.85+1.2%$2.75$1.92▼$3.43$1.06B0.891.31 million shs850,978 shsTHCXAXS Cannabis ETF$16.60$16.60$14.90▼$25.40$141.07M1.7115,071 shsN/A7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBHCBausch Health Cos0.00%-8.86%-7.52%-20.63%-34.59%CRONCronos Group0.00%+0.72%0.00%+4.07%+37.07%THCXAXS Cannabis ETF0.00%0.00%0.00%0.00%0.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBHCBausch Health Cos$4.53+2.1%$5.00$4.33▼$8.69$1.69B0.422.10 million shs1.05 million shsCRONCronos Group$2.85+1.2%$2.75$1.92▼$3.43$1.06B0.891.31 million shs850,978 shsTHCXAXS Cannabis ETF$16.60$16.60$14.90▼$25.40$141.07M1.7115,071 shsN/A7 Stocks to Buy And Hold ForeverClick the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBHCBausch Health Cos0.00%-8.86%-7.52%-20.63%-34.59%CRONCronos Group0.00%+0.72%0.00%+4.07%+37.07%THCXAXS Cannabis ETF0.00%0.00%0.00%0.00%0.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBHCBausch Health Cos 1.83Reduce$8.0076.80% UpsideCRONCronos Group 2.20Hold$2.30-19.16% DownsideTHCXAXS Cannabis ETF 2.00Hold$16.60N/ACurrent Analyst Ratings BreakdownLatest THCX, BHC, and CRON Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/22/2026BHCBausch Health Cos Jefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold5/29/2026CRONCronos Group Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)5/12/2026CRONCronos Group TD SecuritiesSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy5/4/2026BHCBausch Health Cos Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D) ➝ Sell (D-)4/27/2026BHCBausch Health Cos Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetSector Perform$10.00 ➝ $9.00(Data available from 7/27/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBHCBausch Health Cos$10.27B0.16$7.42 per share0.61$1.02 per share4.44CRONCronos Group$146.59M7.24$0.01 per share224.14$3.00 per share0.95THCXAXS Cannabis ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBHCBausch Health Cos$157M-$3.24N/A1.25N/A-11.47%-2,922.77%5.63%7/29/2026 (Estimated)CRONCronos Group-$9.45M$0.01283.78N/AN/A-1.14%-1.26%-1.20%8/6/2026 (Estimated)THCXAXS Cannabis ETFN/AN/AN/AN/AN/AN/AN/AN/AN/ALatest THCX, BHC, and CRON EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/6/2026Q2 2026CRONCronos Group$0.01N/AN/AN/A$44.20 millionN/A7/29/2026Q2 2026BHCBausch Health Cos$0.96N/AN/AN/A$2.59 billionN/A5/11/2026Q1 2026CRONCronos Group$0.01$0.01N/A$0.04$42.20 million$45.21 million4/29/2026Q1 2026BHCBausch Health Cos$0.81$0.78-$0.03-$3.76$2.37 billion$2.46 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBHCBausch Health CosN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ATHCXAXS Cannabis ETF$0.724.34%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBHCBausch Health Cos54.681.320.97CRONCronos GroupN/A21.8720.73THCXAXS Cannabis ETFN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBHCBausch Health Cos78.65%CRONCronos Group8.71%THCXAXS Cannabis ETFN/AInsider OwnershipCompanyInsider OwnershipBHCBausch Health Cos20.67%CRONCronos Group7.80%THCXAXS Cannabis ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBHCBausch Health Cos20,300374.03 million296.72 millionOptionableCRONCronos Group450373.03 million343.94 millionOptionableTHCXAXS Cannabis ETFN/A8.50 millionN/ANot OptionableTHCX, BHC, and CRON HeadlinesRecent News About These CompaniesInnovative Industrial Properties: Cannabis Rescheduling Progress Reinforces The Re-Rating ThesisJune 30, 2026 | seekingalpha.comCannabis Bioscience International Holdings Opens New Revenue Pathway with First VitaCookies Licensing AgreementJune 22, 2026 | newsfilecorp.comNAurora Cannabis: Weak Near-Term Outlook But Too Cheap To Ignore - BuyJune 12, 2026 | seekingalpha.comHerbal Dispatch Completes 452kg Multi Client Medical Cannabis Export Shipment To EuropeJune 9, 2026 | newsfilecorp.comNHerbal Dispatch Completes Export of 261kg of Medical Cannabis to EuropeMay 21, 2026 | newsfilecorp.comNHerbal Dispatch Completes Company Record 500kg Medical Cannabis Export Shipment to EuropeMay 19, 2026 | newsfilecorp.comNAurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis ScienceMay 14, 2026 | prnewswire.comVillage Farms: U.S. Cannabis Optionality (Rating Upgrade)May 13, 2026 | seekingalpha.comGreen Thumb Industries Will Benefit From Medical Cannabis ReschedulingMay 12, 2026 | seekingalpha.comInnovative Industrial Properties: Medical Cannabis Rescheduling Implies Bottoming Tenant Default Risks - Reiterate BuyMay 6, 2026 | seekingalpha.comHerbal Dispatch Launches Next-Generation E-Commerce Platform, Targeting High-Growth $245 Million Insured Medical Cannabis SegmentMay 5, 2026 | newsfilecorp.comNGlow Lifetech Expands Distribution with Two of Canada's Largest Cannabis Retailers, Launches New Product Innovation and Advances National Growth StrategyApril 30, 2026 | newsfilecorp.comNCannabis ETFs: Regulatory Momentum Returns FocusApril 30, 2026 | etftrends.comEHerbal Dispatch Advances U.S. Strategy amid Historic Cannabis Rescheduling ShiftApril 27, 2026 | newsfilecorp.comNAurora Cannabis: Why I Like This StockApril 24, 2026 | seekingalpha.comIM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash FlowMarch 31, 2026 | prnewswire.comCanopy Growth's Apollo Cannabis Clinics Named Best Medical Cannabis ClinicMarch 30, 2026 | businesswire.comHYTN Successfully Releases Cannabis Products in Germany and Accepts ReorderMarch 27, 2026 | globenewswire.comInnovative Industrial Properties: Deeply Undervalued As Cannabis Rescheduling Hits MilestoneMarch 27, 2026 | seekingalpha.comVillage Farms Shows Strong Q4 Performance But Cannabis Sector Remains Weak (Rating Downgrade)March 14, 2026 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTHCX, BHC, and CRON Company DescriptionsBausch Health Cos NYSE:BHC$4.53 +0.10 (+2.14%) As of 02:21 PM Eastern This is a fair market value price provided by Massive. Learn more.Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Cronos Group NASDAQ:CRON$2.84 +0.04 (+1.25%) As of 02:21 PM Eastern This is a fair market value price provided by Massive. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.AXS Cannabis ETF NYSEARCA:THCX$16.60 0.00 (0.00%) As of 03/1/2024The Cannabis ETF (THCX) is an exchange-traded fund that is based on the AXS Cannabis index. The fund tracks an index of legal cannabis companies selected and weighted by market capitalization. The fund primarily holds North American companies but may also invest in other countries. THCX was launched on Jul 9, 2019 and is managed by AXS Investments. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD’s AI Bubble Could Burst Into Explosive Upside Atlassian’s AI Pivot Is Starting to Challenge Wall Street’s Bear Case Apple’s Earnings Setup Puts Its Record Rally and AI Patience to the Test Oil Prices Are Surging and These 4 Stocks Are Cashing In MarketBeat Week in Review – 07/20- 07/24 Telecom Earnings Reveal a Sector That Finally Looks Healthier Forget Tesla: These 2 Earnings Reports Reveal Where the Auto Market Is Heading AMD and Cerebras Create A New Blueprint For Hardware Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
